Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of HRS-7535 in adults with hypertension and overweight or obesity
CTR20261334Phase 3Active
- Sponsor
- Shandong Sende
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HRS-7535 in hypertension (HTN), obesity, Overweight, sponsored by Shandong Sende. Started May 2026; status: active.
02
Drugs
HRS-7535
03
Conditions
hypertension (HTN)obesityOverweight
Beyond the preview
Go deeper on CTR20261334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261334.